Olipudase alfa: Phase II/III started

Sanofi’s Genzyme Corp. unit began the double-blind, placebo-controlled, international Phase II/III ASCEND

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE